reports hero background
Updated: Nov 20, 2026
IVA Logo

Inventiva

NASDAQ:IVA·Stock Analysis Report
Day Range
$3.42 - $3.68
Market Cap
815.01M
P/E Ratio
0.0000
Avg Value
$5.08
Year Range
$2.87 - $7.29
$3.45$0.06 (1.77%)
1
General Information
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.

Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.

2
Inventiva (IVA) Stock Graph
3
How We Grade Inventiva (IVA)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Inventiva (IVA) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

Momentum measures a stock's relative strength based on its price movement patterns and volatility over multiple timeframes, ranked as a percentile against other stocks.

Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
5
Future Growth
Our estimate of future price growth is based on an aggregation of 4 analyst ratings over the past 3 months and their 12-month price targets.

Below, you can see that analysts are estimating a 12-month price target range of $14.00 - $21.00 with an average of $16.75

391.20%
Expected movement for Inventiva (IVA) over the next 12 months
Based on these rankings

Recent Ratings for Inventiva (IVA)

HC Wainwright & Co.
Date:
Nov 5, 2026
Action:
Maintains
Prev. Target:
$24.00
New Target:
$14.00
Truist Securities
Date:
Oct 2, 2026
Action:
Maintains
Prev. Target:
$13.00
New Target:
$18.00
Canaccord Genuity
Date:
Sep 29, 2026
Action:
Maintains
Prev. Target:
$20.00
New Target:
$21.00
Guggenheim
Date:
Sep 15, 2026
Action:
Maintains
Prev. Target:
$11.00
New Target:
$14.00
6
Past Performance
How has Inventiva (IVA) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

Inventiva (IVA) sharpe ratio over the past 5 years is -0.6057 which is considered to be below average compared to the peer average of -0.1119


BenzingaBenzinga Japan